
### [MONDO:0016826](http://purl.obolibrary.org/obo/MONDO_0016826)
**Label:** methylmalonic acidemia with homocystinuria

**Subclasses:** [MONDO:0010183](http://purl.obolibrary.org/obo/MONDO_0010183) (methylmalonic aciduria and homocystinuria type cblF), [MONDO:0010184](http://purl.obolibrary.org/obo/MONDO_0010184) (methylmalonic aciduria and homocystinuria type cblC), [MONDO:0017683](http://purl.obolibrary.org/obo/MONDO_0017683) (methylcobalamin deficiency type cblDv1), [MONDO:0010185](http://purl.obolibrary.org/obo/MONDO_0010185) (methylmalonic aciduria and homocystinuria type cblD), [MONDO:0017685](http://purl.obolibrary.org/obo/MONDO_0017685) (vitamin B12-responsive methylmalonic acidemia, type cblDv2), [MONDO:0013925](http://purl.obolibrary.org/obo/MONDO_0013925) (methylmalonic acidemia with homocystinuria, type cblJ), [MONDO:0010657](http://purl.obolibrary.org/obo/MONDO_0010657) (methylmalonic acidemia with homocystinuria, type cblX), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0038016](http://purl.obolibrary.org/obo/GO_0038016) (insulin receptor internalization), [GO:0032451](http://purl.obolibrary.org/obo/GO_0032451) (demethylase activity), [GO:0002062](http://purl.obolibrary.org/obo/GO_0002062) (chondrocyte differentiation), [GO:0009236](http://purl.obolibrary.org/obo/GO_0009236) (cobalamin biosynthetic process), [GO:0009235](http://purl.obolibrary.org/obo/GO_0009235) (cobalamin metabolic process), [GO:0046972](http://purl.obolibrary.org/obo/GO_0046972) (histone acetyltransferase activity (H4-K16 specific)), [GO:0005158](http://purl.obolibrary.org/obo/GO_0005158) (insulin receptor binding), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0043295](http://purl.obolibrary.org/obo/GO_0043295) (glutathione binding), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0031419](http://purl.obolibrary.org/obo/GO_0031419) (cobalamin binding), [GO:0070988](http://purl.obolibrary.org/obo/GO_0070988) (demethylation), [GO:0071949](http://purl.obolibrary.org/obo/GO_0071949) (FAD binding), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0042626](http://purl.obolibrary.org/obo/GO_0042626) (ATPase activity, coupled to transmembrane movement of substances), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0046325](http://purl.obolibrary.org/obo/GO_0046325) (negative regulation of glucose import), [GO:0045334](http://purl.obolibrary.org/obo/GO_0045334) (clathrin-coated endocytic vesicle), [GO:0043996](http://purl.obolibrary.org/obo/GO_0043996) (histone acetyltransferase activity (H4-K8 specific)), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0046627](http://purl.obolibrary.org/obo/GO_0046627) (negative regulation of insulin receptor signaling pathway), [GO:0009108](http://purl.obolibrary.org/obo/GO_0009108) (coenzyme biosynthetic process), [GO:0043995](http://purl.obolibrary.org/obo/GO_0043995) (histone acetyltransferase activity (H4-K5 specific)), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:1990830](http://purl.obolibrary.org/obo/GO_1990830) (cellular response to leukemia inhibitory factor), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0006749](http://purl.obolibrary.org/obo/GO_0006749) (glutathione metabolic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0051898](http://purl.obolibrary.org/obo/GO_0051898) (negative regulation of protein kinase B signaling), [GO:0033787](http://purl.obolibrary.org/obo/GO_0033787) (cyanocobalamin reductase (cyanide-eliminating) activity), 

**Class expressions from DL-Learner:**

- [GO:0010485](http://purl.obolibrary.org/obo/GO_0010485) (H4 histone acetyltransferase activity) 61.54%
- [GO:0061733](http://purl.obolibrary.org/obo/GO_0061733) (peptide-lysine-N-acetyltransferase activity) 54.84%
- [GO:0004402](http://purl.obolibrary.org/obo/GO_0004402) (histone acetyltransferase activity) 54.84%
- [GO:1900750](http://purl.obolibrary.org/obo/GO_1900750) (oligopeptide binding) 53.85%
- [GO:0071949](http://purl.obolibrary.org/obo/GO_0071949) (FAD binding) 53.85%
- [GO:0050660](http://purl.obolibrary.org/obo/GO_0050660) (flavin adenine dinucleotide binding) 53.85%
- [GO:0046972](http://purl.obolibrary.org/obo/GO_0046972) (histone acetyltransferase activity (H4-K16 specific)) 53.85%
- [GO:0043996](http://purl.obolibrary.org/obo/GO_0043996) (histone acetyltransferase activity (H4-K8 specific)) 53.85%
- [GO:0043995](http://purl.obolibrary.org/obo/GO_0043995) (histone acetyltransferase activity (H4-K5 specific)) 53.85%
- [GO:0043295](http://purl.obolibrary.org/obo/GO_0043295) (glutathione binding) 53.85%
- [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity) 53.85%
- [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding) 53.85%
- [GO:0031419](http://purl.obolibrary.org/obo/GO_0031419) (cobalamin binding) 53.85%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 53.85%
- [GO:0005158](http://purl.obolibrary.org/obo/GO_0005158) (insulin receptor binding) 53.85%


